Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Unveiling Lepromatous Leprosy in a Non-endemic Region: A Case of Delayed Diagnosis and Effective ROM (Rifampin, Ofloxacin, and Minocycline) Therapy

McCarter M, Hassevoort K, Lane J, et al. Springer Science and Business Media LLC. Cureus. 2026;
Download PDF
Publication

Impact of Dapsone (MDT/WHO) on hematological tests of leprosy patients: A retrospective cohort study

da Silva CM, Albertino GS, Wiezel JA, et al. openRxiv. 2025;
Download PDF
Publication

Late Detection with Claw Hand Deformity in a Leprosy Person: A Case Report

Benedict S, Harun Z. Universitas Sumatera Utara. Sumatera Medical Journal. 2026; 9 (1) : 49-52.
Download PDF
Publication

Reactivations, paradoxical reactions, and immune reconstitution in human immunodeficiency virus-associated leprosy: A scoping review of global case patterns, immunopathogenesis, and therapeutic gaps

Anil A, Vellaisamy SG, Manickam N, et al. Ovid Technologies (Wolters Kluwer Health). Indian Journal of Sexually Transmitted Diseases and AIDS. 2025; 46 (2) : 112-118.
Download PDF
Publication

A scoping review of leprosy treatments in the United States, 1996-2025

Koh E, Kernizan F, Eaton W, et al. Elsevier BV. JAAD Reviews. 2026;
Download PDF
Publication

Leprosy elimination: are we winning the fight or losing focus?

Edward M, Owoicho AW. Informa UK Limited. Annals of Medicine. 2025; 57 (1) : 1-9.
Download PDF
Publication

From Nerves to Nodules: A Case-Based Review of the Progression of Pure Neuritic Leprosy to Lepromatous Leprosy With Erythema Nodosum Leprosum

Choubey S, Kar HK, Behera D. Springer Science and Business Media LLC. Cureus. 2025;
Download PDF
Publication

Chronic Anterior Uveitis in A Patient with Treated Leprosy: A Case Report

Azib S, Nejjar Y, Achegri Y, et al. SASPR Edu International Pvt. Ltd. Scholars Journal of Medical Case Reports. 2025; 13 (10) : 2305-2306.
Download PDF
Publication

Optimizing treatment of lepromatous form of leprosy using ofloxacin on top of standard multi-drug therapy in National Referral Hospital, Jakarta, Indonesia.

Priyanto M, Yunifananda M, Menaldi S, et al. F1000Research. 2025;
Download PDF
Publication

Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City

Fonseca AMFDA, Rosa PS, Belone ADFF, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025; 19 (11) : 1-20.
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD